Two widely used drugs for the treatment of erectile dysfunction, tadalafil and vardenafil, trigger an increase in bone mass in mice through a combination of anabolic and anti-resorptive effects on bone, inhibiting the target enzyme, phosphodiesterase 5A (PDE5A) mechanistically (Kim S.-M. The gene discussed is PDE5A; the disease is erectile dysfunction.